Home
Sex, Lies, and Pharmaceuticals: How Drug Companies Plan to Profit from Female Sexual Dysfunction
Loading Inventory...
Barnes and Noble
Sex, Lies, and Pharmaceuticals: How Drug Companies Plan to Profit from Female Sexual Dysfunction
Current price: $17.95
Barnes and Noble
Sex, Lies, and Pharmaceuticals: How Drug Companies Plan to Profit from Female Sexual Dysfunction
Current price: $17.95
Loading Inventory...
Size: Paperback
*Product Information may vary - to confirm product availability, pricing, and additional information please contact Barnes and Noble
Against a backdrop of virtual intercourse, online porn, and burgeoning Viagra sales,
reveals how women’s sexual difficulties are being repackaged as symptoms of a new disorder. In this compelling book, award-winning journalist Ray Moynihan teams up with drug assessment specialist Barbara Mintzes to investigate the creation of female sexual dysfunction or FSD, and the marketing machine that promises to "cure" it. The authors go inside the corridors of medical power to visit drug companysponsored scientific meetings and medical education events where doctors are being trained to see women’s sexual problems as the symptoms of FSD a pharmaceutically treatable condition. Moynihan and Mintzes explore the underlying causes of sexual dissatisfaction among women and expose how global drug companies exploit those problems in an attempt to create the next billion dollar disease.